145 related articles for article (PubMed ID: 25205106)
1. miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression.
Hong CC; Chen PS; Chiou J; Chiu CF; Yang CY; Hsiao M; Chang YW; Yu YH; Hung MC; Hsu NW; Shiah SG; Hsu NY; Su JL
Cancer Res; 2014 Nov; 74(21):6280-90. PubMed ID: 25205106
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Cheng Y; Jiang S; Yuan J; Liu J; Simoncini T
Gynecol Endocrinol; 2018 Oct; 34(10):853-858. PubMed ID: 29658350
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.
Lu P; Qiao J; He W; Wang J; Jia Y; Sun Y; Tang S; Fu L; Qin Y
PLoS One; 2014; 9(2):e88918. PubMed ID: 24551190
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.
Li B; Xu WW; Han L; Chan KT; Tsao SW; Lee NPY; Law S; Xu LY; Li EM; Chan KW; Qin YR; Guan XY; He QY; Cheung ALM
Oncogene; 2017 Jul; 36(28):3986-4000. PubMed ID: 28288140
[TBL] [Abstract][Full Text] [Related]
8. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.
Liu P; Zhou J; Zhu H; Xie L; Wang F; Liu B; Shen W; Ye W; Xiang B; Zhu X; Shi R; Zhang S
Cytokine; 2011 Jul; 55(1):8-17. PubMed ID: 21482472
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-C expression as a biomarker of poor prognosis in esophageal squamous cell carcinoma: a meta-analysis.
Tullavardhana T; Akranurakkul P; Ungkitphaiboon W; Songtish D
Oncol Res Treat; 2015; 38(3):110-4. PubMed ID: 25792082
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies.
Kleespies A; Bruns CJ; Jauch KW
Onkologie; 2005 May; 28(5):281-8. PubMed ID: 15867486
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.
Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H
Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of vascular endothelial growth factor C from multiple specimen sources in esophageal squamous cell carcinoma.
Zhang W; Zhang M; Zhou B; Jia Z; Qiao Z; Zhang J
Int J Biol Markers; 2012 Dec; 27(4):e359-65. PubMed ID: 23125006
[TBL] [Abstract][Full Text] [Related]
13. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
14. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
[TBL] [Abstract][Full Text] [Related]
15. Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma.
Sundaram GM; Veera Bramhachari P
Tumour Biol; 2017 Jun; 39(6):1010428317705760. PubMed ID: 28618941
[TBL] [Abstract][Full Text] [Related]
16. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Sun ZG; Liu XY; Zhang M; Wang Z
Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
[TBL] [Abstract][Full Text] [Related]
18. [Effect of HMGB1 on the VEGF-C expression and proliferation of esophageal squamous cancer cells].
Chen CG; Tang P; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):566-70. PubMed ID: 23158987
[TBL] [Abstract][Full Text] [Related]
19. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
20. Cortactin as a potential predictor of second esophageal neoplasia in hypopharyngeal carcinoma.
Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA
Auris Nasus Larynx; 2019 Apr; 46(2):260-266. PubMed ID: 30107961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
